Skip to main content
. 2020 Nov 20;8:559553. doi: 10.3389/fcell.2020.559553

FIGURE 1.

FIGURE 1

Kaplan–Meier plots showing miR-124-3p clinical relevance on overall survival in (A) a cohort of patients with neuroblastoma tumors of varying stage before chemotherapy (n = 290) and (B) a cohort of patients with high risk neuroblastoma tumors following chemotherapy (n = 41). P-values were obtained using log-rank test.